Brief ReportSurvival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy
Keywords
Cited by (0)
Disclosure: Dr Taioli is the President of the Science and Policy Institute; she receives no compensation for this service. Dr Henschke reports grants from FAMRI outside the submitted work and is a named inventor on a number of patents and patent applications relating to the evaluation of pulmonary nodules on computed tomography scans of the chest that are owned by Cornell Research Foundation (CRF). Since April 2009, Dr Henschke has not accepted any financial benefit from these patents, including royalties and any other proceeds related to the patents or patent applications owned by CRF. In addition, Dr Henschke is the President of the Early Diagnosis and Treatment Research Foundation; she receives no compensation for this service. Dr Yankelevitz reports grants from AstraZeneca and FAMRI outside of the submitted work and is a named inventor on a number of patents and patent applications relating to the evaluation of diseases of the chest, including measurement of nodules. Some of these, which are owned by CRF, are nonexclusively licensed to General Electric. As an inventor of these patents, Dr Yankelevitz is entitled to a share of any compensation that CRF may receive from its commercialization of these patents. The remaining authors declare no conflict of interest.